K2 Therapeutics
Latest round
- Seed
Last raised
- Aug 2026
Total raised
- $50M
Investors
- 1
About K2 Therapeutics
Founded in 2024 and based in Singapore, K2 Therapeutics, Inc. operates as a biotechnology company that develops drug candidates and cell therapies for cancer and other diseases through global drug development programs.
Who invested in K2 Therapeutics
1 investor across 1 round
See all investors in K2 Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Aug 11, 2026
Amount
$50M
Investors
Questions about K2 Therapeutics
Who invested in K2 Therapeutics?
K2 Therapeutics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has K2 Therapeutics raised?
K2 Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did K2 Therapeutics last raise money?
K2 Therapeutics's most recent round on record is a Seed, in Aug 2026.
What does K2 Therapeutics do?
Founded in 2024 and based in Singapore, K2 Therapeutics, Inc.
Where is K2 Therapeutics headquartered?
K2 Therapeutics is headquartered in Singapore, Singapore.
Which VCs invest in companies like K2 Therapeutics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at K2 Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like K2 Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.